Seeking to outpace the market, investors engage in the art of selecting individual stocks. The right picks can play a pivotal role in boosting your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The closing price of Athira Pharma Inc (NASDAQ: ATHA) was $0.65 for the day, up 5.32% from the previous closing price of $0.62. In other words, the price has increased by $5.32 from its previous closing price. On the day, 0.4 million shares were traded. ATHA stock price reached its highest trading level at $0.67 during the session, while it also had its lowest trading level at $0.61.
Ratios:
Our analysis of ATHA’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 2.95 and its Current Ratio is at 2.95. In the meantime, Its Debt-to-Equity ratio is 0.02 whereas as Long-Term Debt/Eq ratio is at 0.02.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Mizuho on September 19, 2024, Downgraded its rating to Neutral and sets its target price to $0.50 from $5 previously.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Sep 05 ’24 when Mark James Litton bought 5,032 shares for $0.00 per share.
Gengos Andrew sold 1,272 shares of ATHA for $720 on Sep 05 ’24. The CFO and Chief Business Officer now owns 97,532 shares after completing the transaction at $0.57 per share. On Sep 05 ’24, another insider, Lenington Rachel, who serves as the COO and CDO of the company, sold 2,525 shares for $0.57 each. As a result, the insider received 1,429 and left with 20,870 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ATHA now has a Market Capitalization of 25250922 and an Enterprise Value of -61532468.
Stock Price History:
Over the past 52 weeks, ATHA has reached a high of $4.30, while it has fallen to a 52-week low of $0.41. The 50-Day Moving Average of the stock is 22.39%, while the 200-Day Moving Average is calculated to be -69.13%.
Shares Statistics:
ATHA traded an average of 5.15M shares per day over the past three months and 449730 shares per day over the past ten days. A total of 38.17M shares are outstanding, with a floating share count of 35.55M. Insiders hold about 8.08% of the company’s shares, while institutions hold 47.77% stake in the company. Shares short for ATHA as of 1728950400 were 1557749 with a Short Ratio of 0.43, compared to 1726185600 on 1645197. Therefore, it implies a Short% of Shares Outstanding of 1557749 and a Short% of Float of 5.7600003.
